Figure 4From: Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate Blood levels of ROS (FORT U) during the EPI treatment and FU in the telmisartan and placebo arms. Back to article page